Evaluation of renal oxidative stress in the development of doca-salt induced hypertension and its renal damage

Clinical and Experimental Hypertension

Volumn 32, Issue 2, 2010, Pages 90-97

  Seifi, Behjat ^a   Kadkhodaee, Mehri ^a   Karimian, Seyed M ^a   Zahmatkesh, Maryam ^a   Xu, Jie ^b   Soleimani, Manoocher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidants; Blood pressure; DOCA salt; Oxidative stress; Renal

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; DEOXYCORTICOSTERONE; N ACETYL BETA GLUCOSAMINIDASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE; CLINICAL EVALUATION; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; CATALASE; DESOXYCORTICOSTERONE; GLUTATHIONE; HYPERTENSION; KIDNEY; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; VITAMIN E;

EID: 77950822403     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960902993111     Document Type: Article

References (35)

1. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD, Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005;45:934-939.
2. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. Journal of Hypertension 1998;16:1267-1271.
3. Bobillier-Chaumont S, Nicod L, Richert L, Berthelot A. Antioxidant status in the liver of hypertensive and metallothionein- deficient mice. Canadian Journal of Physiology and Pharmacology 2003;81:929-936.
4. Elhaimeur F, Nicod L, Courderot-Masuyer C, Robin S, Guyon C, Bouhaddi M, Regnard J, Richert L, Berthelot A. Evolution of liver antioxidant status and iron implication during the development of deoxycorticosterone-saline hypertension in rats. Biological Trace Element Research 2005;107:263-276.
5. Galisteo M, Garcia-Saura MF, Jimenez R, Villar IC, Zarzuelo A, Vargas F, Duarte J. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Molecular and Cellular Biochemistry 2004;259:91-99.
6. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance? Hypertension 2004;44:248-252.
7. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KU, Whitworth JA. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. Journal of Hypertension 2003;21:1513-1518. (Pubitemid 36994130)
8. Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, Schyvens CG, Whitworth JA. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 2005;18:910-916.
9. Courderot-Masuyer C, Lahet JJ, Verges B, Brun JM, Rochette L. Ascorbyl free radical release in diabetic patients. Cellular and Molecular Biology (Noisy-le-Grand, France) 2000;46: 1397-1401.
10. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 2001;218:97-103.
11. Elhaimeur F, Courderot-Masuyer C, Nicod L, Guyon C, Richert L, Berthelot A. Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive male Sprague-Dawley rats and this is associated with increased liver oxidative stress. Molecular and Cellular Biochemistry 2002;237:77-83.
12. Brigelius-Flohe R, Traber MG. Vitamin E: Function and metabolism. Faseb J 1999;13:1145-1155.
13. Newaz MA, Nawal NN. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 1998;11:1480-1485.
14. Ulker S, McKeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534-539.
15. Hasnain BI, Mooradian AD. Recent trials of antioxidant therapy: what should we be telling our patients? Cleveland Clinic Journal of Medicine 2004;71:327-334.
16. Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121-126.
17. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.
18. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-212.
19. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-76.
20. Horak E, Hopfer SM, Sunderman FW, Jr. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem 1981;27:1180-1185.
21. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001;37:781-786.
22. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000;101:1722-1728.
23. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
24. Meng S, Roberts LJ, II, Cason GW, Curry TS, Manning RD, Jr. Superoxide dismutase and oxidative stress in Dahl saltsensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 2002;283:R732-738.
25. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002;39:269-274.
26. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 2003;108:1253-1258.
27. Ichihara A, Hayashi M, Hirota N, Saruta T. Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats. Hypertension 2001;37:630-634.
28. Liu R, Ren Y, Garvin JL, Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int 2004;66:268-274.
29. Juncos R, Garvin JL. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. Am J Physiol Renal Physiol 2005;288:F982-987.
30. Elmarakby AA, Loomis ED, Pollock JS, Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 2005;45:283-287.
31. Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 2003;42:811-817.
32. Dillioglugil MO, Maral Kir H, Gulkac MD, Ozon Kanli A, Ozdogan HK, Acar O, Dillioglugil O. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urologia Internationalis 2005;75:340-344.
33. Sai K, Umemura T, Takagi A, Hasegawa R, Kurokawa Y. The protective role of glutathione, cysteine and vitamin C against oxidative DNA damage induced in rat kidney by potassium bromate. Jpn J Cancer Res 1992;83:45-51.
34. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001;38:606-611.
35. Schyvens CG, Andrews MC, Tam R, Mori TA, Croft KD, McKenzie KU, Whitworth JA, Zhang Y. Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats. Clin Exp Hypertens 2007;29:465-478.